Phase
Condition
Uveitis
Treatment
Placebo PO QD
Brepocitinib PO QD
Brepocitinib 45 mg PO QD
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult subjects (18-75 years old)
Diagnosis of non-infectious uveitis (intermediate uveitis, posterior uveitis, orpanuveitis)
Active uveitic disease in at least 1 eye
Weight > 40 kg with a body mass index ≤ 40 kg/m2
Exclusion
Exclusion Criteria:
Has confirmed or suspected current diagnosis of infectious uveitis History of or have:
Lymphoproliferative disorder
active malignancy
cancer within 5 years prior to screening (exceptions for basal cell carcinoma,squamous cell carcinoma, ductal carcinoma in situ of the breast, carcinoma in situof the uterine cervix, or thyroid carcinoma.)
thrombosis orand cerebrovascularardiovascular ischemic event disease within the last 12 months
a high risk for herpes zoster reactivation
active or recent infections
Study Design
Connect with a study center
Clinical Trial Site
Phoenix, Arizona 85020
United StatesActive - Recruiting
Clinical Trial Site
Bakersfield, California 93309
United StatesActive - Recruiting
Clinical Trial Site
Beverly Hills, California 90211
United StatesActive - Recruiting
Clinical Trial Site
Fullerton, California 92835
United StatesActive - Recruiting
Clinical Trial Site
Irvine, California 92697
United StatesActive - Recruiting
Clinical Trial Site
La Jolla, California 92093
United StatesActive - Recruiting
Clinical Trial Site
Los Angeles, California 90033
United StatesActive - Recruiting
Clinical Trial Site
Modesto, California 95356
United StatesActive - Recruiting
Clinical Trial Site
Sacramento, California 92825
United StatesActive - Recruiting
Clinical Trial Site
Aurora, Colorado 80045
United StatesActive - Recruiting
Clinical Trial Site
Fort Lauderdale, Florida 33308
United StatesActive - Recruiting
Clinical Trial Site
Saint Petersburg, Florida 33711
United StatesActive - Recruiting
Clinical Trial Site
Carmel, Indiana 46290
United StatesActive - Recruiting
Clinical Trial Site
Boston, Massachusetts 02114
United StatesActive - Recruiting
Clinical Trial Site
Waltham, Massachusetts 02451
United StatesActive - Recruiting
Clinical Trial Site
Ann Arbor, Michigan 48105
United StatesActive - Recruiting
Clinical Trial Site
Detroit, Michigan 48201
United StatesActive - Recruiting
Clinical Trial Site
Minneapolis, Minnesota 55455
United StatesActive - Recruiting
Clinical Trial Site
Rochester, Minnesota 55905
United StatesActive - Recruiting
Clinical Trial Site
Saint Louis, Missouri 63108
United StatesActive - Recruiting
Clinical Trial Site
Omaha, Nebraska 68105
United StatesActive - Recruiting
Clinical Trial Site
Palisades Park, New Jersey 07650
United StatesActive - Recruiting
NYU Langone Health
New York, New York 10017
United StatesActive - Recruiting
Clinical Trial Site
Durham, North Carolina 27705
United StatesActive - Recruiting
Clinical Trial Site
Cleveland, Ohio 44106
United StatesActive - Recruiting
Clinical Trial Site
Portland, Oregon 97239
United StatesActive - Recruiting
Clinical Trial Site
Erie, Pennsylvania 16507
United StatesActive - Recruiting
Clinical Trial Site
Philadelphia, Pennsylvania 19107
United StatesActive - Recruiting
Clinical Trial Site
Nashville, Tennessee 37232
United StatesActive - Recruiting
Clinical Trial Site
Austin, Texas 78712
United StatesActive - Recruiting
Clinical Trial Site
Bellaire, Texas 77401
United StatesActive - Recruiting
Clinical Trial Site
Dallas, Texas 75390
United StatesActive - Recruiting
Clinical Trial Site
Houston, Texas 77025
United StatesActive - Recruiting
Clinical Trial Site
Katy, Texas 77494
United StatesActive - Recruiting
Clinical Trial Site
Plano, Texas 75075
United StatesActive - Recruiting
Clinical Trial Site
Round Rock, Texas 78681
United StatesActive - Recruiting
Clinical Trial Site
Madison, Wisconsin 53705
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.